Related Experiment Video
Updated: Oct 17, 2025
12:42
Photoactivated Localization Microscopy with Bimolecular Fluorescence Complementation BiFC-PALM
Published on: December 22, 2015
10.1K
Filling in the GAPs in understanding RAS
Adrienne D Cox1,2,3, Channing J Der1,3
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA.
Science (New York, N.Y.)
|October 7, 2021
Summary
A newly discovered regulator enhances the effectiveness of novel targeted anti-RAS drugs. This finding offers a promising strategy for improving cancer therapy outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- RAS proteins are key drivers in many cancers.
- Targeted therapies against RAS are an area of active research.
- Improving the efficacy of these therapies is crucial for patient outcomes.
Purpose of the Study:
- To identify novel regulators that can enhance the efficacy of targeted anti-RAS drugs.
- To investigate the mechanism by which this regulator affects drug response.
Main Methods:
- Utilized genetic screening to identify potential regulators.
- Performed in vitro and in vivo experiments to validate findings.
- Analyzed molecular pathways affected by the regulator and drug treatment.
Main Results:
- A novel regulator was identified that significantly increases the efficacy of a new class of targeted anti-RAS drugs.
- The regulator was shown to modulate key signaling pathways involved in RAS-driven cancers.
- Combination therapy with the regulator and anti-RAS drugs demonstrated enhanced tumor growth inhibition.
Conclusions:
- The newly identified regulator represents a promising therapeutic target to improve the effectiveness of anti-RAS drugs.
- This discovery opens new avenues for developing combination strategies in oncology.
- Further clinical investigation is warranted to explore the therapeutic potential.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.2K
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
1.3K
Related Concept Videos
02:38The Ras Gene
6.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.5K
01:24Small GTPases - Ras and Rho
4.4K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.4K
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
01:25Rab Cascades
2.8K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
2.8K
01:07MAPK Signaling Cascades
6.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
01:14Rab Proteins
4.3K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.3K